KUALA LUMPUR, Nov 5 (Bernama) -- Bursa Malaysia closed higher, buoyed by Bank Negara Malaysia’s (BNM) decision to maintain the Overnight Policy Rate (OPR) at 2.75 per cent, alongside positive cues from Wall Street. At 5 pm, the FTSE Bursa Malaysia KLCI (FBM KLCI) rose 19.30 points, or 1.19 per cent, to 1,635.86 from Wednesday’s close of 1,616.56. The benchmark index opened 6.72 points higher at 1,623.28, and fluctuated between an intraday high of 1,642.44 and a low of 1,622.62 during the trading session. However, market breadth was negative, with losers outnumbering gainers 723 to 497, while 466 counters were unchanged, 1,075 untraded and 10 suspended. Turnover rose to 3.74 billion units valued at RM3.61 billion compared with yesterday’s 2.81 billion units valued at RM2.57 billion.
Stock up 9.6% — here's why investors are buzzing Breakthrough Spotlight: $Recursion Pharmaceuticals (RXRX.US)$ surged Monday after a WIRED article spotlighted REC-3565 , an AI-designed MALT1 inhibitor drug showing promising early signs in fighting blood cancer . Developed using Recursion’s cutting-edge AI platform, this molecule is something “ humans couldn’t have designed ” through traditional means, according to Peter Ray, Senior Director of Medicinal Chemistry. What Makes This Different? Only 136 molecules were tested to develop REC-617, thanks to AI—vs. thousands in conventional drug discovery REC-3565 is now in Phase 1 trials for relapsed leukemia and B-cell lymphoma Ray believes this is just the start: “Each drug we develop makes the next 10 even better.” Why Investors Care: AI speeds up R&D and slashes costs Real-life patient in REC-617 trial showed miraculous recovery signs Market sees Recursion leading the next-gen ...